FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series B / Biotech startups that raised Series B in New York, United States

Biotech startups that raised Series B in New York, United States

Updated 16 Nov 2026

Reset
Biotech startups that raised Series B in New York, United States
One-time CSV
  • 32 funded companies, 29 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-b~new-york-united-states.csv32 rows × 18 columns
CompanyCityLast roundAmountDate
EvvyNew YorkSeries B$40.0M2026-09-15
ClarapathNew YorkSeries B$36.0M2024-07-24
Retia MedicalWhite PlainsSeries B$15.0M2022-07-18
Massive BioNew YorkSeries B$17.0M2022-06-02
ARMGO PharmaTarrytownSeries B$35.0M2021-12-20
ImmunaiNew YorkSeries B$215.0M2021-10-27
PymetricsNew YorkSeries B$40.0M2018-09-27

7 rows of the CSV in 5 of its 18 columns.

32
Startups
$2.0B
Total raised
3
Funded in the last 12 months
$120.2M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

4 of 32
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Evvy Evvy offers an AI-driven precision medicine platform focused on women's health. Artificial intelligence New York Series B $40.0M 2026-09-15 $59.0M General Catalyst, BoxGroup, Left Lane Capital +2 11 to 50 2021
Massive Bio Massive Bio runs an AI oncology platform that matches patients with clinical trials and gives pharma companies access to them. Artificial intelligence New York Series B $17.0M 2022-06-02 $23.8M 500 Global, 500 Emerging Europe, KFW DEG 101 to 250 2015
Immunai Unicorn Immunai applies machine learning and software engineering to map and reprogram immunology. Artificial intelligence New York Series B $215.0M 2021-10-27 $295.0M 8VC, TLV Partners, Alexandria Venture Investments +2 101 to 250 2018
Pymetrics Pymetrics develops neuroscience-based assessment technology that predicts candidate fit for staffing firms. Artificial intelligence New York Series B $40.0M 2018-09-27 $56.6M MassChallenge, Khosla Ventures, Salesforce Ventures +2 101 to 250 2011

Table 1. Biotech startups that raised Series B in New York, United States: the 4 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 32.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Evvy Evvy offers an AI-driven precision medicine platform focused on women's health. Artificial intelligence New York Series B $40.0M 2026-09-15 $59.0M General Catalyst, BoxGroup, Left Lane Capital +2 11 to 50 2021

Table 2. Biotech startups that raised Series B in New York, United States: the 1 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 G9 Ventures Venture capital firm New York, United States 1 3% 1 Evvy
2 General Catalyst Venture capital firm San Francisco, United States 1 3% 1 Evvy
3 BoxGroup Venture capital firm New York, United States 1 3% 1 Evvy
4 Human Ventures Angel group New York, United States 1 3% 1 Evvy
5 Left Lane Capital Venture capital firm Brooklyn, United States 1 3% 1 Evvy
6 East Post Road Ventures Venture capital firm White Plains, United States 1 3%
7 The CU Healthcare Innovation Fund Venture capital firm Aurora, United States 1 3%
8 Northwell Ventures Corporate venture arm New Hyde Park, United States 1 3%
9 Red Cedar Ventures Venture capital firm East Lansing, United States 1 3%
10 Pritzker/Vlock Family Office Family office Chicago, United States 1 3%
11 KFW DEG Private equity firm Cologne, Germany 1 3%
12 500 Global Startup accelerator Palo Alto, United States 1 3%
13 500 Emerging Europe Venture capital firm San Francisco, United States 1 3%
14 Forbion Capital Partners Private equity firm Naarden, The Netherlands 1 3%
15 Pontifax Venture capital firm Herzliya, Israel 1 3%

Table 3. Biotech startups that raised Series B in New York, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 27 84% $1.8B
Software 6 19% $492.4M
Artificial intelligence 4 12% $434.4M
Hardware 2 6% $22.0M
Fintech 2 6% $350K
Energy 1 3% $350K
Commerce 1 3%

Table 4. Biotech startups that raised Series B in New York, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series B 32 100% $36.0M

Table 5. Biotech startups that raised Series B in New York, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
New York 27 84%
Brooklyn 1 3%
White Plains 1 3%
Tarrytown 1 3%
West Henrietta 1 3%
Orangeburg 1 3%

Table 6. Biotech startups that raised Series B in New York, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
September 2026 1 33% $40.0M
January 2026 1 33% $2.2M
December 2025 1 33% $78.0M

Table 7. Biotech startups that raised Series B in New York, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 2 6% $42.2M
2025 2 6% $78.0M
2024 3 9% $296.0M
2023 2 6% $46.5M
2022 3 9% $32.0M
2021 9 28% $833.4M

Table 8. Biotech startups that raised Series B in New York, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2020 to 2022 5 16%
2015 to 2019 12 38%
2010 to 2014 10 31%
Before 2010 5 16%

Table 9. Biotech startups that raised Series B in New York, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 7 23%
11 to 50 15 48%
51 to 100 4 13%
101 to 250 4 13%
1,001 to 5,000 1 3%

Table 10. Biotech startups that raised Series B in New York, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in New York, United States whose last round is Series B are on the list?
32, in the file dated 16 November 2026. 3 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 32 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series B in New York, United States: 32 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in New York

Other sectors that raised Series B in New York

Cite: FundingWatcher, 32 biotech companies in New York, United States whose most recent round is Series B, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-b/new-york-united-states/